卫光生物：子公司拟参与设立投资基金

Core Viewpoint - Weigao Bio (002880.SZ) announced the establishment of a new private equity investment fund, aiming to invest in strategic emerging industries supported by the Shenzhen Guangming District government [1] Group 1: Fund Establishment - Weigao Bio's subsidiary, Shenzhen Weigao Bio Equity Investment Management Co., Ltd. (Weigao Investment), will collaborate with several partners to set up the Shenzhen Guangming Qihang New Journey Private Equity Investment Fund [1] - The fund is tentatively named and will be subject to final approval by market supervision authorities [1] Group 2: Fund Details - The total scale of the Guangming Qihang New Journey Investment Fund is set at RMB 55 million [1] - Weigao Investment will contribute RMB 16.5 million, holding a 30% share in the partnership [1] Group 3: Investment Focus - The fund will primarily invest in biomedicine, synthetic biology, medical devices, brain science, and other strategic emerging industries encouraged by the Shenzhen Guangming District government [1]